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Abstract
Occurrence of microbubbles (MB) is a major problem during venoarterial 
extracorporeal life support (ECLS) with partially severe clinical complications. The 
aim of this study was to establish an in vitro ECLS setup for the generation and de-
tection of MB. Furthermore, we assessed different MB elimination strategies. Patient 
and ECLS circuit were simulated using reservoirs, a centrifugal pump, a membrane 
oxygenator, and an occluder (modified roller pump). The system was primed with 
a glycerin solution of 44%. Three different revolution speeds (2500, 3000, and 
3400 rpm) were applied. For MB generation, the inflow line of the pump was either 
statically or dynamically (15 rpm) occluded. A bubble counter was used for MB de-
tection. The effectiveness of the oxygenator and dynamic bubble traps (DBTs) was 
evaluated in regard to MB elimination capacities. MB generation was highly depend-
ent on negative pressure at the inflow line. Increasing revolution speeds and restric-
tion of the inflow led to increased MB activity. The significant difference between 
inflow and outflow MB volume identified the centrifugal pump as a main source. 
We could show that the oxygenator’s ability to withhold larger MB is limited. The 
application of one or multiple DBTs leads to a significant reduction in MB count and 
overall gas volume. The application of DBT can significantly reduce the overall gas 
volume, especially at high flow rates. Moreover, large MB can effectively be broken 
down for faster absorption. In general, the incidence of MBs is significantly depend-
ent on pump speed and restriction of the inflow. The centrifugal pump was identified 
as a major source of MB generation.
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1 |  INTRODUCTION
Venoarterial extracorporeal life support (ECLS) is a promising, 
yet a highly invasive therapeutic option in cardiovascular in-
tensive care medicine.1‒3 It is associated with a high incidence 
of complications and recently attention has been directed to 
the emergence of microbubbles (MB) within the circulatory 
system.4,5 MB can lead to neurological morbidity or mortal-
ity due to a cascade of pathophysiological reactions, including 
diffuse cerebral microischemia as well as inflammatory reac-
tions and activation of the complement system.6 There are two 
common ways of MB formation within the ECLS circuit: they 
can form via bubbling due to hypobaric conditions (according 
to the Henry's law)7 or suction can lead to MB by centrifugal 
pumphead‐ or oxygenator‐induced microsplitting.8 As ECLS is 
based on a closed system, the induced MB cannot dissolve into 
the atmosphere as it is the case in an open HLM circuit. Due to 
potential negative sequelae, it is necessary to reduce the occur-
rence of MB to a minimum. The implementation of a venous 
compliance reservoir (eg, Better‐Bladder, etc.) or a pressure 
controlled pump management has been proposed.9,10 But to our 
knowledge, no strategy has been described so far to achieve a 
sufficient reduction of already existing MB.
Thus, the aim of this study was to mimic the MB formation 
in an experimental in vitro ECLS circuit and to evaluate differ-
ent strategies for MB removal including dynamic bubble traps 
(DBTs) and the oxygenator (OXY) without the bubble trap.
2 |  METHODS
2.1 | Basic experimental circuit
For comparability, one experimental in vitro circuit was used 
throughout the whole study (Figure 1). However, parts of the 
system were clamped off and bypassed for the sub‐analyses. 
Standard 3/8″ silicone ECLS tubing (P.h.i.s.o.; Sorin Group, 
Mirandola, Italy) was used to connect the different parts. An ar-
terial and venous tubing length of 180 cm each (typically used in 
clinical settings) was selected. The system was primed with 8 L 
of water‐based media. To mimic the viscosity of human blood 
(4.4 ± 0.6 cP;11), a glycerin solution (44% in distilled water; Roth 
GmbH, Karlsruhe, Germany) was used. The systemic blood 
volume of the patient was simulated by a cardiotomy reservoir 
(Inspire 6F M; Sorin Group S.p.A.). The venous inflow line was 
connected to the inferior outlet and the arterial tube at the top in 
order to minimize the entry of potential MB from the reservoir 
into the experimental circuit. The patient's systemic and the arte-
rial cannula resistances were simulated by the compression of 
the outflow tube using a Hofmann clamp. Resistance was ad-
justed to generate an arterial cannula pressure of 220 mm Hg at 
a flow rate of 4 L/min to simulate typical clinical settings.
A commercially available ECLS system (LifeBox; Sorin 
GmbH) was used. The centrifugal pump was equipped with a 
specific magnetically driven head (Sorin Revolution 5; Sorin 
GmbH). The pump was operated at three different speeds 
during the study: 2500 and 3000 rpm as standard configura-
tions for clinical use and 3400 rpm as the highest reachable 
speed in our setting. A polymethylpentene (PMP) diffusion 
capillary membrane oxygenator (ECMO adult; Eurosets 
S.r.l.; Medolla, Italy) was used for gas exchange. A clinically 
typical oxygen flow rate of 2 L/min was applied to the oxy-
genator in order to generate a counterpressure on the oxygen-
ator membrane and to replace the outgassed volume.
2.2 | Generation of MB
It is known that the hypobaric MB formation can occur es-
pecially in hypovolemic patients.10 Hypovolemia in ECLS 
F I G U R E  1  Experimental setup [Color figure can be viewed at wileyonlinelibrary.com]
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therapy is normally accompanied by rhythmic occlusion 
of the inflow cannula due to recurrent drainage of the total 
blood volume in the blood vessel (eg, vena cava/caval vein) 
and subsequent suction to the vessel’s wall. Another reason 
for hypobaric MB formation is the (static) complete or partial 
occlusion of the inflow cannula due to iatrogenic manipula-
tion or nursing errors.7 In order to simulate these conditions, 
we added a standard roller pump (type 10‐00‐00, Sorin Group 
S.p.A.) to the system and removed one roll. We adjusted the 
occlusion to reduce the tubing volume to approximately 20% 
(resulting from an occlusion of 114 mm leading to a gap size 
of 8 mm and standardized 1/8″ tubing). The inflow (venous) 
line of the ECLS unit was then either statically (stationary 
pump head) or dynamically (rotating pump head; 15  rpm) 
compressed by the roller pump.
2.3 | Different elimination strategies
In this study, different MB elimination strategies were tested. 
The first experimental setting (ES1) measured the MB removal 
capacity of the oxygenator. In a second experimental setting 
(ES2), a DBT (Kardialgut GmbH, Petersdorf, Germany) was 
included into the extracorporeal circuit. Finally, the third ex-
perimental setting (ES3) evaluated the in‐line connection of two 
DBTs. The DBT includes a helix and thereby induces an axial 
rotation of the blood flow. This results in a centrifugal concen-
tration of the MB in the center of the bloodstream. There a by-
pass line separates the bubble‐rich fraction of the blood flow. 
The DBT is made from polycarbonate, has a priming volume 
of 50 mL, and is usually used in the arterial line (3/8″) of a 
heart‐lung‐machine during the extracorporeal bypass. A second 
cardiotomy reservoir was used for the drainage of the bypass 
lines of the DBTs. These bypass lines were linked via Luer con-
nections and a standard infusion line. The relatively low flow 
(275 mL/min at 4 L/min blood flow rate; manufacturer's speci-
fication) enabled a long resting time of the media in the second 
reservoir. This way, potential (micro‐) bubbles were removed 
by gravitation. A connection tube ensured the passive hydro-
static backflow of the media to the main reservoir.
2.4 | Data acquisition
Flow (SCP, Sorin Group S.p.A.) and pressure (SCPC, Sorin 
Group S.p.A.) sensors were used for the assessment of flow 
and pressure characteristics (Figure 1). Both, flow and pres-
sure transducers were attached to the inlet of the centrifugal 
pump. Two additional sensors measured the pressure before 
and after the oxygenator, respectively. The flow rates and 
pressures were measured every minute for the static flow 
restriction runs and every 30 seconds for the dynamic flow 
restriction runs.
Additionally, a specific micro bubble counter (BCC 200; 
GAMPT mbh, Merseburg, Germany) with two Doppler 
effect‐based ultrasound probes was used for MB detection, as 
described elsewhere.12 The device is able to count as well as to 
measure the dimensions of the MB flowing by. Depending on 
the specific test run, the probes were either placed before and 
after the centrifugal pump (generation of MB) or before and after 
the bubble elimination section (evaluation of the elimination 
strategies). The total number, the volume distribution, and the 
overall volume of the MB were documented at the end of each 
run. Due to device properties, MB with a size >500 μm could 
not be differentiated and only their total number was counted.
For a more detailed assessment of the elimination strat-
egies, the removed MB were classified into five differ-
ent groups depending on their size (Table 2): <50  µm := 
very small; 50‐100  µm := small; 100‐150  µm := medium; 
150‐300 µm := large; >300 µm := very large.
2.5 | Experimental design
First, the occurrence of MB was quantified for each pump 
speed (2500, 3000, and 3400 rpm) either with static or dy-
namic compression of the inflow line. Thereafter, different 
MB elimination strategies were assessed during the static 
compression of the inflow line. This resulted in the continu-
ous induction of MB and the elimination capacities of the 
different approaches could thus be determined precisely. 
All setups were tested for 20 minutes and repeated for five 
times (n = 5). To eliminate preexisting MB and influences 
of previous test runs, two techniques were applied: before 
data collection, the system was primed at a pump speed of 
1200 rpm until no MB were detected for at least 5 minutes. 
Additionally, the system was shut down between two experi-
mental runs and rested for at least one hour.
The data gathered from these experiments were then pre-
processed for easier handling in the statistical analysis: the 
raw data collected with the two MB sensors were processed 
to calculate the removal efficiency of the respective strategy. 
The removal efficiency was defined as:
2.6 | Statistical analysis
The Anderson‐Darling test is applied to evaluate if the meas-
ured data is adequately described by the normal distribution. 
Where applicable, data are reported as mean ± standard de-
viation. Differences between the groups were detected by 
performing the unpaired Student's t‐test.
To compare the group means in regard to the statistical 
significance in detail, a multiple regression model with in-
teractions was developed. A two‐way ANOVA test was per-
formed to evaluate the significance of the chosen predictors 
removal efficiency=1−
MBbefore
MBafter
.
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(elimination strategy/pump speed). For post hoc analysis, a 
Tukey test was applied to perform a pairwise comparison 
of the elimination strategies. The α‐level was set at 0.05. 
Data are displayed as box plots with compact letter display.
3 |  RESULTS
3.1 | Flow characteristics and MB activity
Flow characteristics as well as MB formation, the total MB 
volume, and the maximum MB size were assessed at differ-
ent pump speeds (see Table 1). At normal flow conditions, 
three different scenarios with flow rates 2500  rpm 
(4.03  ±  0.02  L/min), 3000  rpm (4.97  ±  0.01  L/min), 
and 3400  rpm (5.78  ±  0.04  L/min) were evaluated. 
Simultaneously, the negative pressure at the inflow of the 
pump increased from −66 to −127 mm Hg. After the static 
compression of the inflow cannula, the flow rate decreased by 
7 ± 1% at all pump speeds and consequently the negative pres-
sure intensified by 46 ± 4%. Dynamic flow restriction showed 
similar, yet weaker effects. The pulsatility of the compression 
is recognizable by varying flow rates (eg, 5.52 ± 0.11 L/min) 
and pressures (eg, −148.15 ± 15.90 mm Hg) where the pres-
sure is affected (SD = 10.7% of mean) greater than the flow 
rate (SD = 2% of mean).
MB were detected in all experimental setups. However, 
we observed major and—to a vast extent—substantial differ-
ences in MB occurrence for the different pump speeds and 
F I G U R E  2  Pressure and MB 
generation depending on occlusion type 
and pump speed. Measurements were 
performed at the inflow and outflow of the 
centrifugal pump. Increasing pump speed 
leads to an increase in the negative pressure. 
It is noteworthy that the type of occlusion 
has a significant effect on the resulting 
MB volume [Color figure can be viewed at 
wileyonlinelibrary.com]
F I G U R E  3  Compact letter display for all pairwise comparisons in regard to MB removal efficiency in regard to MB count (A) and 
volume (B). While the use of an OXY might be a solution at low flow rates (<2500 rpm), its effectiveness decreases significantly at higher 
flow rates. Both DBT strategies show a significant increase in MB volume removal with increasing flow rates [Color figure can be viewed at 
wileyonlinelibrary.com]
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types of flow restriction (static vs. dynamic, Figure 2). From 
2500 to 3400 rpm, we detected a mean increase in the total 
gas volume of 3.29 ⋅106%. Especially large and very large 
MB only occurred at flow rates ≥3000 rpm.
Furthermore, these differences correlated with the negative 
pressure in the experimental setup. Thus, in all inflow restricted 
settings an increase in the pump speed, resulting in increased 
negative pressure, led to an increase in MB generation and a 
higher overall gas volume. This behavior was also observable 
when static or dynamic flow restriction led to higher negative 
pressure with an increase of the number as well as the vol-
ume of the MB and of the overall gas volume. Consequently, 
static flow restriction led to the highest MB activity (number 
and volume). Compared to normal flow, static restriction at 
3400  rpm increased the number of MB by the factor 97 and 
the total volume by the factor 518. However, when normal-
ized to the negative pressure, MB activity was higher in dy-
namic flow restriction (stat.: −143 mm Hg → 289.21 MB; VS 
dyn.:  148.15 ± 15.90 mm Hg → 700.76 MB).
It is notable that the negative pressure alone is not an indi-
cator for MB activity. Results show similar pressure for static 
occlusion at 3000 rpm and dynamic occlusion at 3400 rpm. The 
generated MB volume at dynamic occlusion is three orders of 
magnitude higher than at static occlusion (Figure 2).
It was further observed that the pump itself induced signifi-
cant MB formation. For all experimental settings, a higher num-
ber of MB as well as higher overall gas volumes were detected 
after the pump was compared to prepump measurements. The 
largest difference was detected at normal flow and 3400 rpm. 
Here, the pump generated a 269‐fold increase in the overall gas 
volume (inflow: 0.542 nL → outflow: 146 nL).
3.2 | Different strategies for MB removal
All tested strategies for MB removal showed an influence 
on the number of MB as well as on the total gas volume 
(see Table 2). The sole usage of an OXY (ES1), how-
ever, was only effective at low flow rates. At 2500 rpm, 
more than half of the MB (54.57 ± 2.48%; P <  .01) and 
72.19 ± 4.39% (P < .05) of the total gas volume were re-
moved from the fluid. With increasing flow speeds, the ef-
ficiency of the OXY decreased. The total number of MB 
was not affected, and the gas volume was only reduced 
by 40.87  ±  3.51% (P  <  .05) at 3400  rpm. The two MB 
removal approaches using DBTs showed different results. 
When using one DBT (ES2), 46.77 ± 2.45% (P <  .01) of 
the MB and 66.44 ± 4.75% (P <  .01) of the gas volume 
could be removed at 2500 rpm. Increasing flow rates lead 
to an increased efficiency in gas volume reduction reach-
ing 96.81 ± 0.09% at 3400 rpm. Simultaneously, the effi-
ciency in MB count reduction decreased to 25.36 ± 9.02% 
(P  <  .01). The same tendencies, albeit less pronounced, 
were observed for two DBTs (ES3) in‐line. Here, the 
maximum MB removal capacity was 73.15  ±  8.59% 
(P  <  .05) at 3000  rpm and at 3400  rpm the highest gas 
volume reduction (99.27 ± 0.02%; P < .05) was achieved.
The developed regression model provided an R2 of 0.884 
and an adjusted R2 of 0.859, rendering it sufficiently accurate 
and generalizable. The two‐way ANOVA test proofed statis-
tical significance for both predictors (elimination strategy / 
pump speed) as well as for the interaction of those.
The post hoc Tukey test was performed in regard to elimi-
nation strategies for both the number of MB and their volume. 
Regarding the MB number, we showed a significantly better 
performance of two DBTs compared to an OXY (P < .05) as 
well as compared to only one DBT (P < .001). Relating to the 
MB volume, two DBTs proved   most effective, followed by 
one DBT, rendering the OXY the least effective strategy (all 
P < .001). If the pump speed is considered (Figure 3) it can be 
clearly observed that with increasing flow rates, the efficiency 
of the OXY decreases while the efficiency of the DBT strate-
gies increases. In regard to the MB volume, the OXY proved 
more efficient than one DBT at 2500 rpm. However, as soon as 
the flow rates exceed 3000 rpm, the picture changes drastically.
3.3 | Influence of experimental settings on 
DBT performance
With the above‐described setup, we evaluated the generation 
of MB with focus on their size and total volume distribution. 
This allowed us to evaluate the effect of different elimina-
tion strategies on MB for a specific size range. In the case of 
ES2, an overall reduction of 96.69% of MB volume could be 
achieved. However, if analyzed in regard to the MB size, a 
clear difference can be seen. Small and very small MB can be 
immediately removed (Figure 4A). Large and very large MB 
will be removed effectively as well, but cause  an immense 
increase in small MB (Figure 4B).
4 |  DISCUSSION
MB, also called gaseous microemboli, are a major problem 
in extracorporeal circulation.5 Both, the evaluation of the for-
mation as well as the effective removal of MB from ECLS 
circuits are a focus of current research. In the present study, 
we provide a structured assessment on the development of 
MB in a standard ECLS circuit. Additionally, we investi-
gated widespread removal strategies.
We showed a proportional relation of MB formation to 
the pressure, respectively to suction at the venous (inflow) 
line. In our study, the applied negative pressure depends on 
the rotational speed of the centrifugal pump as well as on the 
(dynamic) restriction of the inflow. These findings are in 
accordance with previously published results.7,10 The high-
est MB activity (number + gas volume) was observed after 
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the static restriction of the inflow line. This is due to the 
higher mean levels of negative pressure. However, the peak 
negative pressure of the dynamic restriction can lead to the 
massive focal occurrence of MB with a low mean negative 
pressure level. As we demonstrated, especially a high MB 
activity is difficult to clear. Beside restriction of the inflow 
line, the pump itself induces a relevant amount of MB. The 
total gas volume as well as the number of MB was signifi-
cantly increased after passing through the pump. Simons et al 
observed the same effect.10 As MB and the total gas volume 
increased, we hypothesize that the occurrence of peak pres-
sures inside the pump leads to the formation of additional 
bubbles.
As it is not possible to completely prevent MB forma-
tion in ECLS therapy, we focused on an effective removal 
strategy. Therefore, we investigated the effectiveness of a 
standard OXY compared to additional application of one or 
two DBT to withhold MB. In previous studies, oxygenators 
showed a high capacity to remove MB even at high counts 
and gas volumes. Simons et al could show a gaseous vol-
ume reduction of at least 92% and Qiu et al achieved a nearly 
complete removal of the gas volume.10,13 In contrast to these 
findings, we were not able to achieve such high removal rates 
in our study. It was only possible to reduce the total gas vol-
ume by 72.19 ± 4.39% and the total count by 54.57 ± 2.48% 
at 2500  rpm. Higher flow rates resulted in an even worse 
result. However, it needs to be taken into consideration that 
microporous membrane oxygenators (Capiox Baby FX05, 
Terumo Corporation, Tokyo, Japan; Quadrox‐series oxygen-
ators, Maquet Cardiopulmonary AG, Hirrlingen, Germany) 
were used in the previously published studies. The Capiox 
oxygenator, for example, is only certified for up to six hours. 
The underlying reason is that microporous oxygenators are 
not completely tight to plasma and could thus lead to leakage 
after longer operation times. Therefore, we used a plasma‐
tight PMP diffusion membrane oxygenator with an approved 
operation time of up to 14 days in our study. Even if less effec-
tive than the microporous oxygenators, the PMP oxygenator 
still showed beneficial effects. A significant reduction of the 
MB at lower flow rates was achieved. At higher flow rates, 
the total reduction capacity was decreasing profoundly and 
bigger MB were probably  split into smaller MB. However, 
smaller MB are considered less dangerous due to their shorter 
lifetime and their reduced risk of microvascular occlusion.14
As another completely new option for MB reduction in 
ECLS therapy, we investigated the removal capacity of a DBT. 
Usually, DBT are used in heart‐lung machines during cardiac 
surgery on cardiopulmonary bypass.15,16 Usage of a DBT suc-
cessfully reduced the total amount of MB as well as the total 
gas volume drastically, even in a setting of high MB activity. 
The best capacity was observed for large and very large MB: 
96.22 ± 3.68% reduction of MB >150 µm and 100% reduc-
tion of MB >300 µm. This supports previous publications.17 
Besides the reduction of large MB, the induction of new small 
MB was detected at higher flow rates. We hypothesize that 
turbulence inside the DBT leads to a partial fragmentation of 
MB. At first look, these results are contradictory to previous 
publications.15,18 However, it needs to be highlighted that only 
MB with a diameter of up to 120 µm were measured in the 
published studies. When just focusing on MB <120 µm we 
also observed an overall reduction of the MB.
In conclusion, with a mean volume reduction of up to 
96.81 ± 0.09%, the application of a DBT leads to an effec-
tive reduction of MB activity. Though the reduction of the 
total number of MB decreased with higher flow rates, the 
gas removal capacity increased. As small MB are less dan-
gerous and since it is more important to reduce the total gas 
load, the DBTs possess significant advantages compared to 
the sole use of an oxygenator.13 Moreover, from this study it 
shows that the flow rate has a significant influence on MB 
removal strategies. While the use of an OXY is effective for 
low flow rates (2500  rpm), at increasing flow rates its ef-
fectiveness drastically declines. The effectiveness of DBTs, 
however, shows a significant increase with increasing flow 
rates (Figure 3) in regard to MB volume.
The application of a second DBT in a series connec-
tion setting achieved a further increased efficiency of up to 
99.27 ± 0.02%. However, in our opinion, the higher costs and 
F I G U R E  4  DBT MB removal 
efficiency depending on the MB size. 
(A) Perfusion with mainly small and very 
small MB. (B) Perfusion with mainly large 
and very large MB. Measurements of the 
inflow sensor are displayed in blue and of 
the outflow sensor in red [Color figure can 
be viewed at wileyonlinelibrary.com]
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the additional bypassed flow outweigh the benefit of an effi-
ciency increase of 2.46% in most cases.
As the ECLS circuit is a closed system, the bypass 
line of a DBT needs to be drained adequately. In femo-
ral ECLS cannulation, drainage into the Shaldon catheter 
(Figure 5) might be an option. The distal limb tissue has 
a much higher ischemic tolerance compared to the brain 
or the heart and is able to resorb the gaseous volume.19 To 
evaluate the feasibility and risk of this option will be the 
focus of further studies.
It needs to be highlighted that the efficiency of the DBT 
strongly depends on the fluid’s viscosity. This was sug-
gested earlier and we were able to experimentally prove 
it in this study.17 In a clinical setting, this is of critical 
relevance, since the blood’s viscosity can change due to 
temperature, hematocrit (volume status), blood flow, and 
other factors.20 Using a water‐glycerin solution we directly 
assessed the fundamental functionality of our approaches 
with less disturbing factors. The results should be transfer-
rable to blood, as the physical principles are the same, but 
further evaluation will be needed.
5 |  CONCLUSION
We were able to provoke the induction of microbubbles in 
an experimental ECLS circuit at different flow rates. This 
clearly shows the immense increase in MB generation at flow 
rates ≥3000  rpm. Evaluation of MB elimination strategies 
demonstrates that PMP diffusion membrane oxygenators are 
highly limited in retaining MBs, especially at higher flow 
rates. Dynamic bubble traps showed a significantly higher 
MB removal efficiency and an increase in effectiveness with 
increasing flow rates. We recommend further investigation 
of this strategy in the setting of ECLS to provide a profound 
basis for the clinical establishment of this approach.
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